Yihong Wang MD PhD
Anatomic Pathology, Clinical Pathology
Assistant Professor, Pathology, Albert Einstein College of Medicine
Join to View Full Profile
593 Eddy StApc 12Providence, RI 02903
Phone+1 401-444-9897
Fax+1 401-444-8514
Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Yihong Wang, MD, is a Pathologist based in Providence, RI, specializing in Anatomic and Clinical Pathology. She completed her residency at Beth Israel Deaconess Medical Center/Harvard Medical School, followed by a fellowship in Selective Pathology focusing on Breast Pathology. Dr. Wang has been the director of breast pathology at Rhode Island Hospital since 2012. Her recent publications include studies on biomarkers and molecular diagnostics in breast cancer.
Education & Training
Beth Israel Deaconess Medical Center/Harvard Medical School Breast PathologyFellowship, Selective Pathology, 2008 - 2009- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Pathology-Anatomic and Clinical, 2004 - 2008
Shandong Medical UniversityClass of 1994
Certifications & Licensure
RI State Medical License 2012 - 2026
NY State Medical License 2009 - 2013
American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- Clinicopathological and molecular analysis of a dermatofibrosarcoma protuberans with fibrosarcomatous transformation in the breast.Liu Liu, Don Dizon, Thomas A DiPetrillo, Jesse Hart, Liang Cheng
NPJ Precision Oncology. 2025-04-15 - p16, COX-2, and Ki67 protein expression in DCIS and risk of ipsilateral invasive breast cancer.Thomas E Rohan, Chenxin Zhang, Yihong Wang, Fergus J Couch, Robert T Greenlee
Cancer Epidemiology, Biomarkers & Prevention. 2025-04-14 - Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study.Thomas E Rohan, Yihong Wang, Fergus Couch, Heather Spencer Feigelson, Robert T Greenlee
Breast Cancer Research and Treatment. 2025-04-01
Journal Articles
- In Reply to Dr. Lambein Et Al “HER2 Protein Overexpression in Non‐Amplified Ductal Carcinoma in Situ: Quality Issue or Transcription Mechanisms Gone Awry?”Yiang Hui, Yihong Wang, Murray B Resnick, Histopathology
- Discordant HER2 Immunohistochemical Expression and Gene Amplification in Ductal Carcinoma in Situ ‐ Evaluating HER2 in Synchronous in Situ and Invasive CarcinomaYiang Hui, Shaolei Lu, Murray B Resnick, Yihong Wang, Histopathology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
